referring to clevelandjewishnews
Panel explores breast cancer in Ashkenazi Jews
Panel explores breast cancer in Ashkenazi Jews
Beachwood, OH (44122)TodayCloudy this morning.Scattered thunderstorms developing this afternoon.Winds W at 5 to 10 mph.Chance of rain 40%..TonightScattered thunderstorms early, then cloudy skies after midnight.
in addition fiercebiotech
Mayo Clinic researchers draw connection between microbiome and cancer from the same human breast tissue
Mayo Clinic researchers draw connection between microbiome and cancer from the same human breast tissue
The diverse community of bacteria that coexist in the human body has recently garnered great interest in medicine.For example, microorganisms found in the gut (also known as the gut microbiota) have been linked to inflammation and metabolic syndrome as well as other diseases.Now, researchers have found bacterial DNA in breast tissue biopsies that appear to be different in composition between women with and without breast cancer.The study was done at the Mayo Clinic and headed up by Tina Hieken.
furthermore fiercebiotech
Lilly's abemaciclib-Faslodex breast cancer combo trial not stopping early
Lilly's abemaciclib-Faslodex breast cancer combo trial not stopping early
Eli Lilly ($LLY) will continue its late-stage breast cancer cocktail trial after its CDK4/CDK6 candidate, when used alongside AstraZeneca's ($AZN) marketed Faslodex (fulvestrant), did not show strong enough data to stop early.The Monarch 2 Phase III trial, as part of its protocol, was briefly paused for an independent Data Monitoring Committee (DMC) to assess its survival numbers.The DMC said the study could go on "Without modification as the interim efficacy criteria were not met."This trial, one of a number studying abemaciclib, saw the drug combined with Astra's med and pitted against placebo and Faslodex in women with hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) locally advanced or metastatic breast cancer.The Big Pharma would have hoped that the DMC found some stellar data and stopped the trial early--but is keen to stress that its continuation is still a positive for the company.
No comments:
Post a Comment